SUSAN SUGLIA: Open Payments
NPI 1164167763 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 64 payments from 12 companies in 2025. Trend: 2023 $1,098 · 2024 $959 · 2025 $2,205
Food & beverage: $1,992Education: $213
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $447 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $359 |
| ABBVIE INC. | 16 | $351 |
| Janssen Biotech, Inc. | 8 | $308 |
| Organon LLC | 10 | $229 |
| Regeneron Healthcare Solutions, Inc. | 4 | $199 |
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| Galderma Laboratories, L.P. | 1 | $84 |
| Janssen Scientific Affairs, LLC | 2 | $73 |
| Lilly USA, LLC | 1 | $26 |
Products named: Bimzelx, TREMFYA, SKYRIZI, VTAMA, DUPIXENT, ILUMYA, COSENTYX, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
